Around 70% of human cancers showed deregulation of Myc (Sorolla et al., 2020), and has been suggested as a target for molecular therapeutics (Duffy et al., 2021; Sorolla et al., 2020; Wang et al., 2021). This evidence concerns the gene MYC and cancer.